Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia
暂无分享,去创建一个
G. Garcia-Manero | A. Quintás-Cardama | K. Hoshino | B. Sánchez‐González | H. Yang | Hong Yang | A. Quintás-Cardama
[1] Hui Yang,et al. Antileukemia activity of the combination of 5-aza-2'-deoxycytidine with valproic acid. , 2005, Leukemia research.
[2] J. Issa,et al. Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] F. Prósper,et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. , 2004, Blood.
[4] D. Fabbro,et al. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia , 2004, Nature Genetics.
[5] V. Radha,et al. Physical and Functional Interaction between Hck Tyrosine Kinase and Guanine Nucleotide Exchange Factor C3G Results in Apoptosis, Which Is Independent of C3G Catalytic Domain* , 2003, Journal of Biological Chemistry.
[6] Kohzoh Imai,et al. Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia. , 2003, Blood.
[7] J. Griffin,et al. Molecular mechanisms of transformation by the BCR-ABL oncogene. , 2003, Seminars in hematology.
[8] M. Warmuth,et al. The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains , 2003, Leukemia.
[9] N. Donato,et al. BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. , 2003, Blood.
[10] Oncogenes and Tumor Suppressors (795 articles) Review Articles (434 articles) , 2003 .
[11] Matthew B. Wilson,et al. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells , 2002, The EMBO journal.
[12] Terry L. Smith,et al. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] J. Issa,et al. DNA methylation patterns at relapse in adult acute lymphocytic leukemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[15] M. Toyota,et al. Methylation profiling in acute myeloid leukemia. , 2001, Blood.
[16] Yao-chang Chen,et al. Methylation of the p15INK4B gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation , 2001, British journal of haematology.
[17] A. Wolffe,et al. DNA methylation in health and disease , 2000, Nature Reviews Genetics.
[18] N. Heisterkamp,et al. Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications. , 2000, Blood.
[19] S. Courtneidge,et al. Src family tyrosine kinases and growth factor signaling. , 2000, Experimental cell research.
[20] S. Krichevsky,et al. ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. , 1999, Blood.
[21] S. Clark,et al. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. , 1999, Cancer research.
[22] J. Herman,et al. CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Kraker,et al. Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth , 1999, Leukemia.
[24] J. Issa,et al. Methylation of the ABL1 promoter in chronic myelogenous leukemia: lack of prognostic significance. , 1999, Blood.
[25] M. Warmuth,et al. The Src Family Kinase Hck Interacts with Bcr-Abl by a Kinase-independent Mechanism and Phosphorylates the Grb2-binding Site of Bcr* , 1997, The Journal of Biological Chemistry.
[26] P. Laird,et al. COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.
[27] S. Krichevsky,et al. Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemia. , 1997, Blood.
[28] M. Warmuth,et al. Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. , 1996, Cancer research.